IP Library › Assignment 051613/0030
Patent Assignment
Reel/Frame 051613/0030

Assignment of Assignor's Interest

Recorded: 2020-01-24 Pages: 8
Assignors
BEARSS, DAVID J.
Executed: 2020-01-21
WARNER, STEVEN L.
Executed: 2020-01-22
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property (1)
ALK5 Inhibitors for Treating Myelodysplastic Syndrome
Application: 16/740,219 →
Publication: US 2020/0323851
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0344 →
Change of Name Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0663 →
Change of Name Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger Oct 27, 2023
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 065377/0580 →